Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YTHDF2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | PACRGL | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | MRPL41 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | XCL1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | C21orf2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | THAP9 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | CCER2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | OBSCN | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | EID1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |